| # | Drug | Count |
|---|---|---|
| 0 | ROSUVASTATIN | 76 |
| 1 | METFORMIN | 61 |
| 2 | ASPIRIN | 59 |
| 3 | ASPIRIN 325 MG | 55 |
| 4 | ASPIRIN 81 MG | 55 |
| 5 | METFORMIN ER 500 MG | 55 |
| 6 | METFORMIN ER 750 MG | 55 |
| 7 | ADALIMUMAB | 54 |
| 8 | ATORVASTATIN CALCIUM | 52 |
| 9 | EVOLOCUMAB | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METRELEPTIN | 7 | 0.0055 |
| 1 | CUPRIC OXIDE | 2 | 0.0045 |
| 2 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 6 | 0.0034 |
| 3 | ICOSAPENT ETHYL | 29 | 0.0033 |
| 4 | RILPIVIRINE | 16 | 0.0022 |
| 5 | DEFLAZACORT | 5 | 0.0019 |
| 6 | LOMITAPIDE MESYLATE | 6 | 0.0016 |
| 7 | BEXAROTENE | 2 | 0.0015 |
| 8 | INCLISIRAN | 12 | 0.0014 |
| 9 | RALTEGRAVIR | 7 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 88 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 74 |
| 2 | Benzodiazepine [EPC] | 71 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 63 |
| 4 | Proton Pump Inhibitor [EPC] | 58 |
| 5 | PCSK9 Inhibitor [EPC] | 54 |
| 6 | beta-Adrenergic Blocker [EPC] | 50 |
| 7 | Corticosteroid [EPC] | 47 |
| 8 | Atypical Antipsychotic [EPC] | 46 |
| 9 | Vitamin C [EPC] | 46 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 7 | 0.0055 |
| 1 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 2 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 3 | PCSK9 Inhibitor [EPC] | 54 | 0.0021 |
| 4 | Provitamin D2 Compound [EPC] | 34 | 0.0011 |
| 5 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 6 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 44 | 0.0008 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0005 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |